glp-1 drugs key developments 2025 2.0: Where the Next Wave of Value Will Be Created GLP-1 trends 2025: real-world data,

The half-life of GLP-1(7-37) in plasma is 1 to 2 min, necessitating the use of an infusion to deliver it in sufficient amounts

The accumulated evidence from CVOTs has not only informed clinical practice guidelines but has also empowered healthcare providers with a valuable therapeutic option for T2D patients who have high cardiovascular risk

Additionally, the GLP-1 agonist increases satiety, leading to fewer cravings and helping individuals make healthier food choices

Ask your doctor about patient assistance programs

"Without this coordination, there's a risk employees receive medication without addressing the broader behavioral health needs that drive alcohol-related absenteeism, healthcare costs and safety concerns." Read more: Based on the people she's spoken with at Eleanor Health, Harrison said that most clinicians are excited about "At the same time, most clinicians view GLP-1s as a potential complement, not a replacement, for established addiction care," she said